Find us on FaceBookFollow Us On Twitter
Home | Appointments | About The Center
Johns Hopkins Arthritis CenterJohns Hopkins Medicine
  • Arthritis Info
  • Patient Resources
  • Physician Resources
  • Arthritis News
  • Arthritis Research
  • Ask The Expert
ACR 2006 Highlights from Johns Hopkins University
Home > Physician Corner > Physician Education > ACR 2007 Highlights > Gout

Gout Highlights

  • Abstract 518: Placebo-Controlled Pilot Study of Rilonacept (IL-1 Trap), A Long Acting IL-1 Inhibitor, In Refractory Chronic Active Gouty Arthritis
  • Abstract 755: Mouse IL-1 Trap Reduces Pain and Inflammation in Animal Models of Gout
  • Abstract 757: Urate-Lowering Therapy (Febuxostat [FEB] or Allopurinol [ALLO]) in Subjects with Gout: Interim Results from the Febuxostat Comparative Extension Long-Term Study (EXCEL)
  • Abstract 758: Gout Flare Incidence in Relation to Average Serum Urate during the First Year of Urate-Lowering Therapy
  • Abstract #756 Disordered Osteoclast Development in Patients with Tophaceous Gout; Uric Acid Crystals Promote Osteoclastogenesis Through Interactions with Stromal Cells

AddThis Social Bookmark Button

  • ACR 2007 Highlights
  • Rheumatoid Arthritis
  • Clinical Aspects
  • Safety
  • TNF Antagonists
  • Treatment
  • Spondyloarthropathies
  • Pediatric Rheumatology
  • Osteoarthritis
  • Gout
  • Lupus
  • Myositis
  • Osteoporosis
  • Scleroderma
  • Sjogrens Syndrome
  • Vasculitis
  • Basic Science
  • Epidemiology
  • ACR 2006 Highlights
  • CME Activities
  • ACR Daily Highlights
  • ACR Daily Podcasts
  • ACR Skyscape PDA Highlights
  • ACR Toolkit
  • CME Activity Home

Signup For Our Email Newsletter

Sitemap | Copyright |Privacy Policy | RSS |Contact Us | Johns Hopkins Rheumatology